UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Personal Protective Equipment: Protecting Health Care Providers in an Ebola Outbreak

Clinical therapeutics, 2015-11, Vol.37 (11), p.2402-2410

2015

Volltextzugriff (PDF)

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Nature communications, 2022-08, Vol.13 (1), p.4931-4931, Article 4931

2022

Volltextzugriff (PDF)

COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2

PloS one, 2021-12, Vol.16 (12), p.e0260879-e0260879

2021

Volltextzugriff (PDF)

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody

PLoS pathogens, 2024-04, Vol.20 (4), p.e1011680

2024

Volltextzugriff (PDF)

Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center

PloS one, 2022-12, Vol.17 (12), p.e0277707-e0277707

2022

Volltextzugriff (PDF)

All-Cause and Cause-Specific Mortality Among Black and White North Carolina State Prisoners, 1995–2005

Annals of epidemiology, 2011-10, Vol.21 (10), p.719-726

2011

Volltextzugriff (PDF)

Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Nature communications, 2023-01, Vol.14 (1), p.333-333, Article 333

2023

Volltextzugriff (PDF)

Protecting healthcare personnel from acquiring Ebola virus disease

Infection control and hospital epidemiology, 2015-10, Vol.36 (10), p.1229-1232

2015

Volltextzugriff (PDF)

The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone

BMC infectious diseases, 2022-07, Vol.22 (1), p.624-11, Article 624

2022

Volltextzugriff (PDF)

Antiviral Activity, Pharmacokinetics, and Safety of BMS-488043, a Novel Oral Small-Molecule HIV-1 Attachment Inhibitor, in HIV-1-Infected Subjects

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.722-728

2011

Volltextzugriff (PDF)

Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial

PloS one, 2014-05, Vol.9 (5), p.e96187

2014

Volltextzugriff (PDF)

COVID-19 therapies for inpatients: a review and quality assessment of clinical guidelines

ERJ open research, 2022-10, Vol.8 (4), p.236

2022

Volltextzugriff (PDF)

Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)

Antiviral therapy, 2014-01, Vol.19 (2), p.191-200

2014

Volltextzugriff (PDF)

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

Science translational medicine, 2022-01, Vol.14 (628), p.eabl7430

2022

Volltextzugriff (PDF)

Inequities in access to diagnostics threatens global public health security

The Lancet infectious diseases, 2022-06, Vol.22 (6), p.754-756

2022

Volltextzugriff (PDF)

Combining vaccines, optimised supportive care, and therapeutics for Ebola virus disease increases survival

The Lancet infectious diseases, 2024-06, Vol.24 (6), p.560-562

2024

Volltextzugriff (PDF)

Best practices for identifying men who have sex with men for corrections-based pre-exposure prophylaxis provision

Health & justice, 2019-04, Vol.7 (1), p.7-4, Article 7

2019

Volltextzugriff (PDF)

It takes more than a machine: A pilot feasibility study of point-of-care HIV-1 viral load testing at a lower-level health center in rural western Uganda

PLOS global public health, 2023, Vol.3 (3), p.e0001678-e0001678

2023

Volltextzugriff (PDF)

Does HAART efficacy translate to effectiveness? Evidence for a trial effect

PloS one, 2011-07, Vol.6 (7), p.e21824-e21824

2011

Volltextzugriff (PDF)

Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy

PLoS medicine, 2006-03, Vol.3 (3), p.e52-e52

2006

Volltextzugriff (PDF)

All-Cause and Cause-Specific Mortality Among Men Released From State Prison, 1980-2005

American journal of public health (1971), 2008-12, Vol.98 (12), p.2278-2284

2008

Volltextzugriff (PDF)

Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results

Journal of acquired immune deficiency syndromes (1999), 2017-06, Vol.75 (2), p.211-218

2017

Volltextzugriff (PDF)

Timing and Duration of Incarceration and High-Risk Sexual Partnerships Among African Americans in North Carolina

Annals of epidemiology, 2008-05, Vol.18 (5), p.403-410

2008

Volltextzugriff (PDF)

Raltegravir Pharmacokinetics in Treatment-Naive Patients Is Not Influenced by Race: Results from the Raltegravir Early Therapy in African-Americans Living with HIV (REAL) Study

Antimicrobial Agents and Chemotherapy, 2013-02, Vol.57 (2), p.784-788

2013

Volltextzugriff (PDF)

The Impact of Discharge Against Medical Advice on Readmission After Opioid Use Disorder-Associated Infective Endocarditis: a National Cohort Study

Journal of general internal medicine : JGIM, 2023-05, Vol.38 (7), p.1615-1622

2023

Volltextzugriff (PDF)

1 – 25 von 352

Suche als RSS-Feed

Aktive Filter

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(316)
Mit Volltextzugriff
(283)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(216)
Life Sciences & Biomedicine
(181)
Humans
(158)
Male
(100)
Female
(91)
Adult
(85)
Hiv
(78)
Human Immunodeficiency Virus
(75)
Infectious Diseases
(66)
Middle Aged
(60)
Public, Environmental & Occupational Health
(52)
Hiv Infections - Drug Therapy
(46)
Public Health
(40)
Biological And Medical Sciences
(39)
Medical Sciences
(37)
United States
(32)
Viral Diseases
(31)
Adolescent
(30)
Prisoners
(30)
General & Internal Medicine
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Personal Protective Equipment: Protecting Health Care Providers in an Ebola Outbreak

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody

Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center

All-Cause and Cause-Specific Mortality Among Black and White North Carolina State Prisoners, 1995–2005

Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Protecting healthcare personnel from acquiring Ebola virus disease

The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone

Antiviral Activity, Pharmacokinetics, and Safety of BMS-488043, a Novel Oral Small-Molecule HIV-1 Attachment Inhibitor, in HIV-1-Infected Subjects

Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial

COVID-19 therapies for inpatients: a review and quality assessment of clinical guidelines

Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

Inequities in access to diagnostics threatens global public health security

Combining vaccines, optimised supportive care, and therapeutics for Ebola virus disease increases survival

Best practices for identifying men who have sex with men for corrections-based pre-exposure prophylaxis provision

It takes more than a machine: A pilot feasibility study of point-of-care HIV-1 viral load testing at a lower-level health center in rural western Uganda

Does HAART efficacy translate to effectiveness? Evidence for a trial effect

Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy

All-Cause and Cause-Specific Mortality Among Men Released From State Prison, 1980-2005

Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results

Timing and Duration of Incarceration and High-Risk Sexual Partnerships Among African Americans in North Carolina

Raltegravir Pharmacokinetics in Treatment-Naive Patients Is Not Influenced by Race: Results from the Raltegravir Early Therapy in African-Americans Living with HIV (REAL) Study

The Impact of Discharge Against Medical Advice on Readmission After Opioid Use Disorder-Associated Infective Endocarditis: a National Cohort Study

Aktive Filter

Suchergebnisse filtern